Stay updated on Azacitidine Combo with Pembrolizumab & Epacadostat Clinical Trial
Sign up to get notified when there's something new on the Azacitidine Combo with Pembrolizumab & Epacadostat Clinical Trial page.

Latest updates to the Azacitidine Combo with Pembrolizumab & Epacadostat Clinical Trial page
- Check3 days agoChange DetectedA site-wide banner announces an NIH terminology transition, noting that NIH content may use “Super Intelligence” alongside “Artificial Intelligence.”SummaryDifference1%

- Check10 days agoChange DetectedThe footer now identifies the site as revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check17 days agoChange DetectedThe revision label in the page footer changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check37 days agoChange DetectedThe page now shows a 403 Forbidden error with a minimal header and a Home link, replacing the full study record content; the detailed study documents and related sections are no longer visible.SummaryDifference20%

- Check59 days agoChange DetectedThe revision label on the page updated from v3.6.5 to v3.6.6, reflecting a newer page revision in the site’s metadata. This change does not alter content or behavior.SummaryDifference0.0%

- Check66 days agoChange DetectedA new funding/identifier line '2016 ( U.S. NIH Grant/Contract )' was added to the study's identifiers, signaling NIH support for the trial.SummaryDifference0.0%

Stay in the know with updates to Azacitidine Combo with Pembrolizumab & Epacadostat Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Azacitidine Combo with Pembrolizumab & Epacadostat Clinical Trial page.